These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 10805406)

  • 1. Short-term NO synthase inhibition and the Na+-binding properties of cardiac Na,K-ATPase.
    Vrbjar N; Strnisková M; Pechánová O; Gerová M
    Physiol Res; 2000; 49(1):65-70. PubMed ID: 10805406
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Short-term NO synthase inhibition and the ATP affinity of cardiac Na,K-ATPase.
    Vrbjar N; Strnisková M; Pechánová O; Gerová M
    Physiol Res; 2002; 51(6):565-9. PubMed ID: 12511179
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Functional alterations of cardiac (Na,K)-ATPase in L-NAME induced hypertension.
    Vrbjar N; Bernátová I; Pechánová O
    Gen Physiol Biophys; 1999 Dec; 18 Suppl 1():10-2. PubMed ID: 10707824
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Changes of sodium and ATP affinities of the cardiac (Na,K)-ATPase during and after nitric oxide deficient hypertension.
    Vrbjar N; Bernátová I; Pechánová O
    Mol Cell Biochem; 1999 Dec; 202(1-2):141-7. PubMed ID: 10706004
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Changes of sodium and ATP affinities of the renal Na,K-ATPase during and after nitric oxide-deficient hypertension.
    Vrbjar N; Javorková V; Pechánová O
    Physiol Res; 2002; 51(5):475-81. PubMed ID: 12470200
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dual effect of polyphenolic compounds on cardiac Na+/K+-ATPase during development and persistence of hypertension in rats.
    Vlkovicová J; Javorková V; Mézesová L; Pechánová O; Andriantsitohaina R; Vrbjar N
    Can J Physiol Pharmacol; 2009 Dec; 87(12):1046-54. PubMed ID: 20029541
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of maturation on renal Na+/K+-atpase and its susceptibility to nitric oxide-deficient hypertension in rats.
    Javorková V; Vlkovicova J; Kunes J; Pechanova O; Zicha J; Vrbjar N
    Clin Exp Pharmacol Physiol; 2007 Jul; 34(7):617-23. PubMed ID: 17581218
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of nitric oxide synthesis inhibition on the Na,K-ATPase activity in the kidney.
    Kang DG; Kim JW; Lee J
    Pharmacol Res; 2000 Jan; 41(1):123-7. PubMed ID: 10600280
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulatory role of nitric oxide on the cardiac Na, K-ATPase in hypertension.
    Vlkovičová J; Javorková V; Mézešová L; Pecháňová O; Vrbjar N
    Physiol Res; 2008; 57 Suppl 2():S15-S22. PubMed ID: 18373397
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sodium and ATP affinities of the cardiac (Na,K)-ATPase in relation to nitric oxide synthesis in spontaneously hypertensive rats.
    Vrbjar N; Pechánová O
    Life Sci; 2002 Aug; 71(15):1751-61. PubMed ID: 12151053
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sodium and ATP affinities of the cardiac Na(+),K(+)-ATPase in spontaneously hypertensive rats.
    Vrbjar N; Wachalová K; Sipola M; Vapaatalo H
    Gen Physiol Biophys; 2002 Sep; 21(3):303-13. PubMed ID: 12537353
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nitric oxide regulates cardiac intracellular Na⁺ and Ca²⁺ by modulating Na/K ATPase via PKCε and phospholemman-dependent mechanism.
    Pavlovic D; Hall AR; Kennington EJ; Aughton K; Boguslavskyi A; Fuller W; Despa S; Bers DM; Shattock MJ
    J Mol Cell Cardiol; 2013 Aug; 61():164-71. PubMed ID: 23612119
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of L-arginine on Na+,K+-ATPase activity in rat aorta endothelium.
    Akopova OV; Kharlamova ON; Vavilova GL
    Biochemistry (Mosc); 2002 Sep; 67(9):1058-61. PubMed ID: 12387723
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nitric oxide synthase inhibition by L-NAME prevents the decrease of Na+,K+-ATPase activity in midbrain of rats subjected to arginine administration.
    Wyse AT; Bavaresco CS; Bandinelli C; Streck EL; Franzon R; Dutra-Filho CS; Wajner M
    Neurochem Res; 2001 May; 26(5):515-20. PubMed ID: 11513478
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased expression of sodium transporters in rats chronically inhibited of nitric oxide synthesis.
    Kim JS; Choi KC; Jeong MH; Kim SW; Oh YW; Lee JU
    J Korean Med Sci; 2006 Feb; 21(1):1-4. PubMed ID: 16479055
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Defective nitric oxide production impairs angiotensin II-induced Na-K-ATPase regulation in spontaneously hypertensive rats.
    Javkhedkar AA; Lokhandwala MF; Banday AA
    Am J Physiol Renal Physiol; 2012 Jan; 302(1):F47-51. PubMed ID: 21900450
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Brain cell membrane Na+,K(+)-ATPase activity after inhibition of cerebral nitric oxide synthase by intravenous NG-nitro-L-arginine in newborn piglets.
    Groenendaal F; Mishra OP; McGowan JE; Delivoria-Papadopoulos M
    Biol Neonate; 1995; 68(6):419-25. PubMed ID: 8721886
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chronic nitric oxide synthase inhibition exacerbates renal dysfunction in cirrhotic rats.
    Graebe M; Brond L; Christensen S; Nielsen S; Olsen NV; Jonassen TE
    Am J Physiol Renal Physiol; 2004 Feb; 286(2):F288-97. PubMed ID: 14583432
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Spermidine decreases Na⁺,K⁺-ATPase activity through NMDA receptor and protein kinase G activation in the hippocampus of rats.
    Carvalho FB; Mello CF; Marisco PC; Tonello R; Girardi BA; Ferreira J; Oliveira MS; Rubin MA
    Eur J Pharmacol; 2012 Jun; 684(1-3):79-86. PubMed ID: 22497998
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Competitive inhibition of (Na/K)-ATPase by furylethylenes with respect to potassium ions.
    Breier A; Vrbanová A; Docolomanský P; Bohácová V; Ziegelhöffer A
    Gen Physiol Biophys; 1996 Aug; 15(4):291-307. PubMed ID: 9088927
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.